French scientists developed an antibody that beats chemo resistance in pancreatic cancer
Pancreatic cancer is highly lethal, with only about 13% of patients surviving five years after diagnosis, according to the American Cancer Society. N…
Pancreatic cancer is highly lethal, with only about 13% of patients surviving five years after diagnosis, according to the American Cancer Society. N…
A Chilean researcher has developed a probiotic that inhibits the growth of the cancer-associated bacterium Helicobacter pylori in the stomach while a…
An international study suggests that many women with early-stage breast cancer can safely skip chemotherapy without affecting their chances of succes…
Russian authorities have announced the development of an experimental mRNA-based cancer vaccine, using the same technology employed in some COVID-19 …